Sector Chart Evolent Health, Inc.

Equities

Market Closed - Nyse Other stock markets 01:30:02 15/05/2024 am IST			5-day change	1st Jan Change
23.85 ^USD	+0.42%		-13.62%	-27.79%

14/05	Truist Adjusts Evolent Health's Price Target to $28 From $34, Notes Near-Term Lack of Claims Visibility; Keeps Hold Rating	MT
10/05	UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes